Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA rejection
Biotech
Minerva's schizophrenia drug rejected by FDA for 2nd time
Minerva's schizophrenia drug has been rejected by the FDA, which said the studies to support approval did not establish evidence of effectiveness.
Annalee Armstrong
Feb 27, 2024 9:34am
With FDA rejection for eye drug, Aldeyra plans speedy new trial
Nov 28, 2023 4:30am
FDA reverses rejection of Vivos mouthpiece for sleep apnea
Jan 4, 2023 11:12am
BrainStorm shares tumble as FDA again knocks back ALS drug
Nov 10, 2022 10:05am
Omeros' Hail Mary throw for blood clot med delayed at FDA
Aug 17, 2022 11:21am
FDA denies Lumos Diagnostics' rapid test submission
Jul 11, 2022 10:45am